BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6584630)

  • 61. Intravaginal prostaglandin E2 for cervical ripening and initiation of labor. Comparison of a multidose gel and single, controlled-release pessary.
    Smith CV; Rayburn WF; Miller AM
    J Reprod Med; 1994 May; 39(5):381-4. PubMed ID: 8064705
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mid-second-trimester labor induction: concentrated oxytocin compared with prostaglandin E2 vaginal suppositories.
    Winkler CL; Gray SE; Hauth JC; Owen J; Tucker JM
    Obstet Gynecol; 1991 Feb; 77(2):297-300. PubMed ID: 1988897
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Management of missed abortion and fetal death in utero.
    el-Damarawy H; el-Sahwi S; Toppozada M
    Prostaglandins; 1977 Sep; 14(3):583-90. PubMed ID: 905580
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Labor induction in intrauterine fetal death].
    Butterwegge M; Gethmann U; Ohlenroth G
    Zentralbl Gynakol; 1990; 112(21):1335-9. PubMed ID: 2278217
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vaginal misoprostol in managing premature rupture of membranes.
    Ayad IA
    East Mediterr Health J; 2002; 8(4-5):515-20. PubMed ID: 15603033
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Second-trimester abortion by intramuscular 15-methyl-prostaglandin F2 alpha or intravaginal prostaglandin E2 suppositories: a randomized trial.
    Borgida AF; Rodis JF; Hanlon W; Craffey A; Ciarleglio L; Campbell WA
    Obstet Gynecol; 1995 May; 85(5 Pt 1):697-700. PubMed ID: 7724098
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Induced second trimester abortion by extra-amniotic prostaglandin infusion in patients with a cesarean scar: is it safe?
    Shapira S; Goldberger S; Beyth Y; Fejgin MD
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):511-4. PubMed ID: 10376860
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A simpler approach to labor induction using lipid-based prostaglandin E2 vaginal suppository.
    MacKenzie IZ; Bradley S; Embrey MP
    Am J Obstet Gynecol; 1981 Sep; 141(2):158-62. PubMed ID: 6945046
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prostaglandin E2 vaginal suppositories in the treatment of intractable late-onset postpartum hemorrhage. A case report.
    Goldstein AI; Kent DR; David A
    J Reprod Med; 1983 Jun; 28(6):425-6. PubMed ID: 6604156
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Postconception menses induction using prostaglandin vaginal suppositories.
    Foster HW; Smith M; McGruder CE; Richard F; McIntyre J
    Obstet Gynecol; 1985 May; 65(5):682-5. PubMed ID: 3982746
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of three concentrations of intracervical prostaglandin E2 gel for cervical ripening.
    Voss DH; Cumminsky KC; Cook VD; Nethers MS; Spinnato JA; Gall SA
    J Matern Fetal Med; 1996; 5(4):186-93. PubMed ID: 8796792
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Vaginal administration prostaglandin E2 in premature ruptured membranes at term with an unfavorable cervix].
    Carbonne B; Goffinet F; Cabrol D
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(8):783-91. PubMed ID: 9026504
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical application of prostaglandins in obstetrics and gynecology.
    Brunnberg FJ
    Acta Biol Med Ger; 1976; 35(8-9):1243-7. PubMed ID: 1007783
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dramatic pyrexic and cardiovascular response to intravaginal prostaglandin E2.
    Phelan JP; Meguiar RV; Matey D; Newman C
    Am J Obstet Gynecol; 1978 Sep; 132(1):28-32. PubMed ID: 696780
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of vaginal prostaglandin-E2 suppositories in septic abortion.
    Milano CT; Gleicher N
    Prostaglandins; 1980 Mar; 19(3):455-6. PubMed ID: 7384552
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The use of prostaglandin E2 vaginal suppository in missed abortion, intrauterine death and hydatidiform mole.
    Takagi LR; Gulling EA; O'Leary JA
    J Med Assoc Ga; 1978 Aug; 67(8):644-5. PubMed ID: 574529
    [No Abstract]   [Full Text] [Related]  

  • 77. Uterine rupture with the use of vaginal prostaglandin E2.
    Elder MG
    Am J Obstet Gynecol; 1985 Oct; 153(3):342. PubMed ID: 3863485
    [No Abstract]   [Full Text] [Related]  

  • 78. Induction and augmentation of labor in hypertensive patients with intravenous prostaglandin E2.
    Thiery M; Benijts G; Derom R; Martens G; Amy JJ; van Kets H; Schryver DE
    Z Geburtshilfe Perinatol; 1977 Oct; 181(5):345-51. PubMed ID: 605644
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Preparation of the uterine cervix before induction of labor using the prostaglandin E2 (PGE2) vaginal tablet].
    Lomícková T; Mandys F; Kovarík J
    Cesk Gynekol; 1987 Feb; 52(1):18-24. PubMed ID: 3552266
    [No Abstract]   [Full Text] [Related]  

  • 80. Mechanism of failed labor after fetal death and its treatment with prostaglandin E2.
    Schulman H; Saldana L; Lin CC; Randolph G
    Am J Obstet Gynecol; 1979 Apr; 133(7):742-52. PubMed ID: 434019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.